ArticleScience signaling2025

Reporter-based screening identifies RAS-RAF mutations as drivers of resistance to active-state RAS inhibitors in colorectal cancer.

Oleksandra Aust et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.